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DOI 10.1016/j.stem.2008.06.019Somatic cells can be reprogrammed to in-
duced pluripotent stem (iPS) cells by ret-
roviral transduction of four transcription
factors, Oct4, Sox2, Klf4, and c-Myc (Ta-
kahashi and Yamanaka, 2006; Takahashi
et al., 2007; reviewed in Jaenisch and
Young, 2008). While the reprogrammed
pluripotent cells are thought to have
great potential for regenerative medicine
(Hanna et al., 2007; Wernig et al.,
2008b), genomic integrations of the retro-
viruses, especially c-Myc, increase the
risk of tumorigenesis (Okita et al., 2007).
Recently, iPS cells have been generated
without c-Myc retrovirus (Myc[]), but in
the absence of exogenous c-Myc the effi-
ciency and kinetics of reprogramming are
significantly reduced (Nakagawa et al.,
2008; Wernig et al., 2008a). We report
here that soluble Wnt3a promotes the
generation of iPS cells in the absence of
c-Myc retrovirus. These data demon-
strate that signal transduction pathways
and transcription factors can act coordi-
nately to reprogram differentiated cells
to a pluripotent state.
Naturally occurring signaling mole-
cules that modulate the expression of
endogenous embryonic stem cell (ESC)
transcription factors are promising candi-
dates for soluble factors that enhance
reprogramming. The Wnt signaling path-
way contributes to the maintenance of
pluripotency in mouse and human ESCs
(Sato et al., 2004; Ogawa et al., 2006; Sin-
gla et al., 2006; Cai et al., 2007) as well as
the self-renewal of undifferentiated adult
stem cells in multiple tissues (Reya and
Clevers, 2005). In addition, initial studies
of iPS cell generation suggested that
constitutively active b-catenin, another
downstream component of the Wnt path-
way, might promote reprogramming of
fibroblasts to pluripotency (Takahashi132 Cell Stem Cell 3, August 7, 2008 ª2008and Yamanaka, 2006). Studies of Tcf3,
one of the key transcriptional regulators
downstream of the Wnt pathway in
embryonic stem cells, have revealed that
this factor co-occupies almost all pro-
moter regions occupied by ESC-specific
transcription factors, including Oct4 and
Nanog, and can regulate the expression
of key ESC transcription factors (Cole
et al., 2008; Tam et al., 2008; Yi et al.,
2008).
Since the Wnt pathway is intimately
connected to the core circuitry of pluripo-
tency, we hypothesized that the stimula-
tion of the pathway using soluble factors
could modulate the efficiency of inducing
pluripotency in somatic cells. Here we ex-
amined the influence of Wnt stimulation
on the reprogramming of murine fibro-
blasts in the absence of c-Myc retrovirus.
For this, cells with GFP driven by the
endogenous Oct4 promoter (Meissner
et al., 2007) were infected with doxycy-
cline (DOX)-inducible lentiviruses encod-
ing Oct4, Sox2, and Klf4. Oct4/Sox2/
Klf4-infected cells were either cultured in
standard ESCmedium or inWnt3a-condi-
tioned medium (Wnt3a-CM) and were
analyzed for GFP expression by flow cy-
tometry at days 10, 15, and 20 after DOX
induction. No GFP-positive cells were
present with or without Wnt3a-CM treat-
ment on day 10 or day 15. By day 20,
a small population of GFP-expressing
cells was detected only in the cells cul-
tured in Wnt3a-CM (Figure 1A). The
Wnt3a-CM-exposed cultures formed
GFP-expressing colonies with morphol-
ogy typical for ES or iPS cells
(Figure 1B). However, unlike four factor-
transduced cells, which usually form a
highly heterogeneous population of cells
when propagated without selection,
the Oct4/Sox2/Klf4/Wnt3a-CM coloniesElsevier Inc.appeared homogenously ESC-like, simi-
lar to previously reported Myc[] iPS
clones (Nakagawa et al., 2008).
Several assays were performed to
characterize the developmental potential
of Myc[] iPS cells derived with Wnt3a-
CM treatment. Immunocytochemistry
confirmed the expression of markers of
pluripotency, including the nuclear factor
Nanog and the surface glycoprotein
SSEA1 (Figure 1B). Functional assays
confirmed that, like ESCs, these iPS cells
were pluripotent. When injected into SCID
mice subcutaneously, the Myc[] iPS cells
gave rise to teratomas with histological
evidence of cells differentiating into all
three germ layers (Figure 1C). More
importantly, Myc[] iPS cells derived with
Wnt3a-CM treatment contributed to the
formation of somatic tissues as well as
the germline in chimeric mice (Figures
1D and 1E and see Table S1 available
online). These results indicate that
Wnt3a-CM-treated Myc[] clones are plu-
ripotent cells that are morphologically and
functionally indistinguishable from ESCs.
To quantify the effects of Wnt3a-CM,
triplicate experiments were performed
on Oct4/Sox2/Klf4-inducible MEFs car-
rying a G418 resistance cassette down-
stream of the Oct4 promoter (Figure 2A).
G418 was added to the cultures at
15 days post-DOX induction to select for
cells that had reactivated the Oct4 locus.
When scored on day 28 post-DOX induc-
tion, only a few Myc[] G418-resistant
colonies (between zero and three colonies
forming on each 10 cm plate) were
detected in standard ESC culture condi-
tions. In contrast, 20-fold more drug-
resistant colonies formed when G418
selection was initiated on Wnt3a-CM-
treated cells, consistent with the conclu-
sion that activation of the Wnt pathway
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noted that conditioned medium from con-
trol fibroblasts (L cells, ATCC) lacking
Wnt3a overexpression also caused
a moderate increase in the number of
G418-resistant colonies relative to stan-
dard ES medium, suggesting that normal
fibroblasts may secrete factors, perhaps
including Wnt3a, that promote reprog-
ramming. So far, we have been unable
to recapitulate the effects of Wnt3a-CM
on reprogramming with small molecule in-
hibitors of glycogen synthase kinase-3
(Gsk3) that modulate the Wnt pathway
and promote the self-renewal of ESCs
(Sato et al., 2004; Ying et al., 2008)
(Figure S1). While there are many plausi-
ble explanations for this negative result,
one possibility is that the half-life of these
chemicals is too short to provide sus-
tained stimulation of the Wnt pathway re-
quired to enhance reprogramming.
To independently assess the effect of
Wnt3a on reprogramming, we cultured
cells in the presence of ICG-001 (Teo
et al., 2005; McMillan and Kahn, 2005),
an inhibitor of theWnt/b-catenin pathway.
Figure 2A (right columns) shows that 4mM
ICG-001 strongly inhibited the effect of
Wnt3a-CM on Myc[] iPS formation. The
Figure 1. Wnt3a Promotes Reprogramming
of Somatic Cells to Pluripotency
(A) Scatter plots comparing GFP intensity to auto-
fluoresence, using flow cytometry, in Oct4-GFP
cells on day 20 postinduction of Oct4/Sox2/Klf4,
reveal a GFP-expressing population of cells (indi-
cated with an arrow) only with Wnt3a-CM treat-
ment (right), not in the control (Ctrl) Oct4/Sox2/
Klf4-infected cells cultured in standard ESC
medium (left).
(B) Phase contrast micrographs (Phase, left) of
GFP-expressing Myc[] cells derived with Wnt3a-
CM treatment and without any genetic selection.
Immunostaining reveals induction of pluripotency
markers, Nanog (upper), and SSEA-1(lower) in
Wnt3a-CM-treated Myc[] cells.
(C) Wnt3a-CM-treated Myc[] lines formed tera-
tomas when injected into SCID mice
subcutaneously. Teratomas from Oct4/Sox2/Klf4/
Wnt3a-CM iPS lines showed evidence of differen-
tiated cells of three germ layers similar to tera-
tomas formed from V6.5 mES injections. Arrows
indicated neural tissue in (upper), cartilage in (mid-
dle), and endodermal cells in (lower).
(D) Oct4/Sox2/Klf4/Wnt3aCM iPS lines derived
without selection gave rise to chimeric mice (as
shown on the left) with agouti coat color and pig-
mented eyes (in contrast to wild-type BALB/c
mouse, right), providing evidence of contribution
to somatic cells.
(E) Agouti coat color of offspring (left) of chimeric
mouse (right) confirmed that the Oct4/Sox2/Klf4/
Wnt3a-CM iPS line generated here is germline
competent.ll 3, August 7, 2008 ª2008 Elsevier Inc. 133
Cell Stem Cell
Correspondenceeffects of Wnt3a-CM and ICG-001 were
also examined in MEFs overexpressing
all four reprogramming factors, including
c-Myc (Figure 2B). High numbers of
G418-resistant colonies were observed
in both standard ESC media (66 colo-
nies/32 cm2) and Wnt3a-CM in four factor
reprogrammed cells, with only a subtle
increase in the number of colonies with
Wnt3a-CM (80 colonies/32 cm2). In con-
trast to the dramatic effect of ICG-001 on
Myc[] cells, at the same dose, the com-
pound had only a subtle effect on the
number of G418 colonies in c-Myc-trans-
duced cells, and a relatively high number
of resistant colonies were observed under
these conditions (51 colonies/32 cm2)
(Figure 2B). When the experiment was
Figure 2. Wnt/b-Catenin Stimulation Enhances iPS Colony Formation in Absence of c-Myc
Retrovirus
(A) Counts are shown for G418-resistant colonies inOct4/Sox2/Klf4-overexpressingMEFs cultured in ESC
media, control L cell-conditioned media (ATCC), Wnt3a-overexpressing conditioned media (ATCC), and
Wnt3a-overexpressing conditioned media with ICG-001 (4 mM). Selection was initiated on day 15 post-
DOX induction, and colonies were assessed on day 28. Wnt3a-CM treatment was maintained for 6–9
days after selection was initiated. Mean number of counts from triplicate experiments is displayed, with
error bars indicating SD.
(B) Counts are shown forG418-resistant colonies (in a 32 cm2area) inOct4/Sox2/Klf4/c-Myc-overexpress-
ing MEFs cultured in ESC media, Wnt3a-overexpressing conditioned media (ATCC), and Wnt3a-overex-
pressing conditioned media with ICG-001 (4 mM). Selection was initiated on day 10 post-DOX induction,
Wnt3a-CM was maintained for the first 6–9 days of selection, and colonies were assessed on day 20.
(C)Wnt stimulation promotes the formaton of iPS cells in the absence of c-Myc transduction. This could be
due to (1) direct regulation by the Wnt pathway of key endogenous pluripotency factors, such as Oct4,
Sox2, and Nanog, as suggested by genomic studies in ESCs (Cole et al., 2008); (2) Wnt pathway-induced
activation of endogenousMyc (He et al., 1998; Cole et al., 2008); or other cell proliferation genes, acceler-
ating the sequential process of forming iPS colonies.
134 Cell Stem Cell 3, August 7, 2008 ª2008 Elsevier Inc.repeated with higher doses of ICG-001,
iPS colony numberswere further reduced,
but even at 25 mM multiple Oct4/Sox2/
Klf4/c-Myc iPS colonies were observed
(mean = 8 colonies/32 cm2) (Figure S2).
These data suggest that Wnt signaling
and c-Myc could have overlapping, but
not completely redundant, roles in the in-
duction of pluripotency.
Recent reports have demonstrated that
Myc is dispensable for inducing pluripo-
tency in MEFs (Nakagawa et al., 2008;
Wernig et al., 2008a), establishing Oct4,
Sox2, and Klf4 as a core set of reprogram-
ming factors, although a slightly different
combination of factors also functions in
human cells (Yu et al., 2007). Epigenetic
reprogramming of MEFs with defined fac-
tors is a gradual process in which tran-
scription factors progressively reestablish
the core circuitry of pluripotency over the
course of weeks (Brambrink et al., 2008;
Stadtfeld et al., 2008). Myc accelerates
this process (Nakagawa et al., 2008; Wer-
nig et al., 2008a), conceivably because
it enhances cell proliferation, allowing
the changes to unfold more rapidly. Addi-
tionally, Myc is suspected to have
widespread effects on chromatin state
(Knoepfler, 2008; Kim et al., 2008) and
could facilitate the productive binding of
the core reprogramming factors to their
appropriate genomic targets (Jaenisch
and Young, 2008).
The Wnt signaling pathway has been
shown to connect directly to the core
transcriptional regulatory circuitry of
ESCs, suggesting a mechanism by which
this pathway could directly promote the
induction of pluripotency in the absence
of c-Myc transduction (Figure 2C). In
ESCs, Tcf3 occupies and regulates the
promoters of Oct4, Sox2, and Nanog
(Cole et al., 2008; Tam et al., 2008; Yi
et al., 2008). In MEFs, these endogenous
pluripotency transcription factors are
silenced. During reprogramming, as ex-
ogenous Oct4, Sox2, and Klf4 contribute
to the reactivation of the endogenous
pluripotency factors (Jaenisch and
Young, 2008),Wnt signaling could directly
potentiate the effect of these transcription
factors, as it does in ESCs (Cole et al.,
2008).
Additionally, Wnt could serve to acti-
vate endogenous c-Myc directly, thereby
substituting for exogenous c-Myc
(Figure 2C). Indeed, c-Myc is a well-
established target of the Wnt pathway in
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ESCs, Tcf3 occupies the c-Myc promoter,
and Wnt3a positively contributes to ex-
pression of the gene (Cole et al., 2008).
However, quantitative PCR studies did
not reveal Wnt3a-CM-dependent activa-
tion of c-Myc during the first 48 hr after
induction of Oct4/Sox2/Klf4 in MEFs
(Figure S3). Although we cannot exclude
that Wnt3a enhances c-Myc expression
in the rare cells that will eventually be-
come iPS cells, the expression data sug-
gest that the role ofWnt in reprogramming
could be independent of c-Myc induction,
consistent with recent findings in ESCs
(Ying et al., 2008). Wnt signaling and c-
Myc could play partially redundant func-
tional roles in iPS cell generation. For
example, Wnt-induced effects on cell
proliferation could help to accelerate the
sequence of events that lead to the
generation of Myc[] iPS colonies.
A major goal of current research is to
identify transient cues that can reprogram
somatic cells, eliminating the need for ret-
roviruses. The studies described here es-
tablish that Wnt stimulation can be used
to enhance the efficiency of reprogram-
ming in combination with nuclear factors
Oct4, Sox2, and Klf4. By enhancing the
efficiency of reprogramming in the ab-
sence of c-Myc retrovirus, soluble Wnt,
or small molecules that modulate the
Wnt signaling pathway, will likely prove
useful in combination with other transient
cues, yet to be identified, that can replace
the remaining retroviruses.
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